Scientific Research News
News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder
Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX
Discovery Revealed in New Book Just Released by The Oaklea Press Has the Potential to Extend the Human Lifespan
Discovery by a PhD and credentialed laboratory scientist about the amnio acid glycine could add years of good health to the lives of those who suffer, or potentially might suffer, from inflammation associated with disorders such as arthritis, diabetes, cardiovascular disease and cancer. - November 18, 2024 - The Oaklea Press
Recode Ventures, in Partnership with Lilly, Launches Recode Edge, a Multi-Million Dollar Program to Enable AI-Powered Healthcare Innovations
Recode Ventures is excited to announce Eli Lilly and Company (Lilly) as the Founding Partner of Recode Edge, a groundbreaking multi-million dollar investment program for early-stage AI-first healthcare startups. Recode Edge is open to innovative founders worldwide who are building AI-driven solutions to tackle some of the most critical challenges in healthcare. The most promising companies will receive equity investment to support their growth and impact. - November 12, 2024 - Recode Ventures
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
Provocative SF Comedy Novel “Sex On the Wrong Brain”, Site, Suggest Fascism is a Masturbation Problem That Can be Reduced with a Simple Planetary Sex Ed Lesson
The provocative theory presented in the science fiction comedy novel "Sex On the Wrong Brain" and website of the same name suggests control of women and anti abortion extremism are part of the sexual repression used for centuries to increase frustration and masturbation needed to fuel the irrational need for certainty that drives authoritarianism. - November 01, 2024 - SOWB (Sex On the Wrong Brain)
Dr. Vidhya Rangaraju Wins Prestigious NIH Director’s New Innovator Award for Research on Brain Energy Mechanisms
Dr. Vidhya Rangaraju of the Max Planck Florida Institute for Neuroscience (MPFI) has been awarded the prestigious NIH Director’s New Innovator Award for her groundbreaking research on how the brain generates and regulates energy. - October 10, 2024 - Max Planck Florida Institute for Neuroscience
Tobias International Launches Comprehensive SolarWinds Managed Services
Tobias International, the leader in SolarWinds Professional Services announces SolarWinds Managed Services. - October 03, 2024 - Tobias International
Glucolate Unveils Breakthrough Diabetic Study
Glucolate Unveils Breakthrough Study from University of California, Irvine: New Powder Form Reduces Glucose Absorption in Type 2 Diabetics Glucolate, an innovative leader in diabetes management, is proud to announce groundbreaking findings from a recent study conducted at the University of... - October 02, 2024 - Glucolate Processing, LLC
Claims of Fraud and Forgeries May Debunk 500 Years of Christopher Columbus History
With Columbus Day just around the corner, Italians may wish to reconsider their annual street parades. The Italian Christopher Columbus may have been debunked and dethroned in a new doctoral dissertation titled "COLUMBUS versus COLÓN: The weaver from Italy was not the navigator from Spain," being released this October 10, 2024. - October 01, 2024 - Association Cristovao Colon
Superior Rail & Iron Works Named First-Ever Diamond Sponsor for ALS TDI’s White Coat Affair Gala
The ALS Therapy Development Institute (ALS TDI) has announced that Superior Rail & Iron Works, Inc. will be the first-ever Diamond Sponsor for the annual White Coat Affair gala, taking place on October 5, 2024, at the Boston Sheraton. Superior Rail & Iron Works, Inc., which was the gala’s Title Sponsor last year, is continuing its support, helping ALS TDI push forward with critical research to find treatments for ALS. - September 19, 2024 - ALS Therapy Development Institute
US Biologic, Inc. and the Agricultural Research Service Announce Breakthrough Oral Alternative to Antibiotics for Poultry
US Biologic, Inc. and the U.S. Department of Agriculture’s Agricultural Research Service (ARS) announce today findings of a new alternative to antibiotics in the face of coccidiosis and antimicrobial resistance, which cost the poultry industry $3.5B in annual losses worldwide and endanger the... - September 17, 2024 - US Biologic, Inc.
Cromos Pharma Announces the Opening of a New Office in Portugal
Cromos Pharma has opened a new office in Lisbon, Portugal, expanding its presence in Southern Europe. Portugal’s robust healthcare system, EU regulatory alignment, and diverse patient population make it an ideal site for clinical trials. This expansion bolsters Cromos Pharma’s European operations and underscores its commitment to patient-centered research, offering its "No Patients – No Payment" model to minimize sponsor risk. - September 17, 2024 - Cromos Pharma
Sama Therapeutics and Quine Biologics Announce Collaboration to Develop Breakthrough Antibody Therapeutics for Neurological Disorders
Sama Therapeutics and Quine Biologics have partnered to develop an innovative therapy for neurological disorders, combining AI-driven platforms and advanced antibody engineering. The collaboration focuses on biologics that precisely target the central nervous system, minimizing side effects. By integrating Sama's generative AI with Quine's antibody design expertise, the project addresses unmet medical needs and advances treatments for conditions like Alzheimer’s and multiple sclerosis. - September 13, 2024 - Quine Biologics, Inc.
SEMA Lab Launches Crowdfunding Campaign for Ultrasound-Enhanced Meditation Retreat
The Science Enhanced Mindful Awareness (SEMA) Lab, co-directed by Dr. Jay Sanguinetti and world-renowned mindfulness teacher Shinzen Young, has officially launched a crowdfunding campaign to support their latest research endeavor: the world’s first ultrasound-enhanced meditation retreat. - September 13, 2024 - SEMA Lab
Former Microsoft Asia Research Institute VP, Dr. Jiangsen Tian, Joins Yushan.AI Corporation to Lead LLM Development
Dr. Jiangsen Tian, former Vice President of Microsoft Asia Research Institute, has officially joined Yushan.AI Corp. as Chief AI Scientist. - September 12, 2024 - Yushan.AI Corporation
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
Cinematographer Kevin Otterness Joins "The Travelers Team" Project
Renowned Chicago-based cinematographer to lend his expertise to 6MP Films' debut sci-fi feature film "The Travelers Team" set for production in early 2025. - August 23, 2024 - 6MP Films
Registration is Open for the Ohio State University’s Fall 2024 Corrosion Short Course
The OSU Fall 2024 course will be offered online with recorded video lectures and lab demonstrations - August 23, 2024 - Gamry Instruments
PCOS Awareness Association and Milan Laser Hair Removal Present: Empower & Illuminate - a PCOS Advocacy Event
In a powerful collaboration aimed at raising awareness and advocating for those affected by Polycystic Ovarian Syndrome (PCOS), the PCOS Awareness Association and Milan Laser Hair Removal are proud to announce the "Empower & Illuminate: A PCOS Advocacy Event." This groundbreaking... - August 21, 2024 - PCOS Awareness Association
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor
Blink Device Company announces the launch of the TwitchView®2 System, the second generation of its electromyographic (EMG) quantitative neuromuscular monitoring system. A complete redesign based on experience in over 1,000,000 clinical cases around the world. Designed to withstand OR abuse and to perform reliably in even the most difficult-to-monitor patients. - August 14, 2024 - Blink Device Company
New Study Explores Potential Benefits of Biophoton Generators in Alzheimer's Care
Study results shared at Alzheimer's Association International Conference in Philadelphia. - July 30, 2024 - Tesla BioHealing, Inc.
Thrombolex and Aidoc Announce Strategic Partnership to Advance Breakthrough Pulmonary Embolism Treatment
Thrombolex, Inc., an innovator in the development of advanced interventional medical devices for the treatment of thromboembolic disease, and Aidoc, a pioneering force in clinical AI, are pleased to announce a strategic partnership aimed at revolutionizing the treatment of acute pulmonary embolism... - July 30, 2024 - Thrombolex, Inc.
Busch Marine Inc. is Launching a Search Mission for the Wreck of SS I’m Alone
Busch Marine Inc., with locations in Plainwell, Freeland, and Carrollton Michigan, is embarking on a search mission for the wreck of the SS I’m Alone. This deep ocean search will be conducted in the Gulf of Mexico at a depth of 12,000 to 16,000 feet. The SS I’m Alone was a renowned... - July 24, 2024 - Busch Marine Inc.
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
Huntington Study Group Announces Launch of LEAD-HD Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group
Morningbird Space Corporation Announces Release of Its Revolutionary 3D Printer Backed by NASA
The Electronic Alchemy eforge series 3.1 is a revolutionary 3D printer capable of creating fully functional electronic devices. The printer was supported by NASA SBIR/STTR and is ready for pre-order. Sensors, circuits, elements, wearable tech, biotechnology, rapid prototyping, and much more is capable with the proprietary filaments from this groundbreaking FDM machine. - July 11, 2024 - Morningbird Space Corporation
ADAM Aerospace Announces Expansion of Current Air Force and Space Force Contract to Now Include Generative AI Application
ADAM Aerospace, an advanced cryptography and cybersecurity company, today announced the expansion of its current advanced cryptography contract with the United States Air Force and Space Force to include artificial intelligence capabilities within its latest SaaS technology, BASE. The new advances allow ADAM to include generative AI and large language models for DoD use cases. - June 29, 2024 - ADAM Aerospace
Daicel Arbor Biosciences Launches New myTXTL® Kits to Accelerate Protein Expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS... - June 27, 2024 - Daicel Arbor Biosciences
SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility
SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx
M4 Engineering Inc. Acquires Phoenix Technology Works a New Prototyping Powerhouse is Created
M4 Engineering Inc., a leading Engineering, Test, and Prototyping firm in the field of conceptual design, analysis and product development has acquired Phoenix Technology Works (PTW) Maricopa, AZ to increase its footprint in full vehicle prototyping and tooling for composite applications. The... - June 14, 2024 - M4 Engineering
National Freshwater Foundation Granted 501(c)(3) Nonprofit Status by Internal Revenue Service
In a significant leap forward for freshwater conservation and sustainability, the National Freshwater Foundation is thrilled to announce its official IRS designation as a 501(c)(3) nonprofit organization. The IRS determined that the National Freshwater Foundation is a public charity under section 509(a)2. - June 10, 2024 - National Freshwater Foundation
Terrestrial Energy Joins Texas Nuclear Alliance as a Founding Member
The Texas Nuclear Alliance (TNA) is proud to announce that Terrestrial Energy has joined the Alliance as a Founding Member. Terrestrial Energy is at the forefront of nuclear innovation with its Integral Molten Salt Reactor (IMSR). TNA is the only industry association dedicated to the advancement of the nuclear industry in Texas. - June 07, 2024 - Texas Nuclear Alliance
Gamry Instruments to Host Free Webinar Sponsored by Kolibrik
Kolibrik.net will sponsor a Free Webinar hosted by Gamry and presented by PinFlow Energy Storage. - June 07, 2024 - Gamry Instruments
Gamry Instruments Marks 35th Anniversary
Gamry Instruments Celebrates 35 Years and Going Strong. From Gamry’s start in 1989 they have created electrochemical instruments with uncommon value and performance. - June 05, 2024 - Gamry Instruments
Immundiagnostik, Inc. Launches New and Improved Website
Immundiagnostik, Inc. announces the launch of its new and improved website, making it easier for researchers and clinical lab professionals to find the immunoassays and ELISAs they need. - June 03, 2024 - Immundiagnostik, Inc.
International Perinatal Stem Cell Society, Inc. and TRI-PAC Health and Wellness Advocacy Have Formed a Strategic Alliance to Advance Stem Cell Legislation
The International Perinatal Stem Cell Society, Inc. and TRI-PAC Health and Wellness Advocacy have formed a strategic alliance to advocate for legal access to safe, effective, and affordable stem cell therapies in the United States. They propose adopting the Japanese model for stem cell therapy regulation, allowing patients to participate in paid clinical trials. The partnership aims to draft and propose a federal bill to improve patient access to stem cell and tissue therapies. - May 24, 2024 - International Perinatal Stem Cell Society, Inc.
Suabix™ Now Live; Revolutionizing Healthcare with Cutting-Edge AI Human Factors Copilot and Consulting Services for Product Development Teams
Suabix™ by Successful Human Factors™, is the first AI Human Factors Copilot for medical product teams, revolutionizing the future of healthcare and patient safety. Successful Human Factors™ is also offering AI integration services tailored to stakeholders needs, powered by Suabix. - May 21, 2024 - Successful Human Factors™
Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu
No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption
Thar Process, with 34 years of expertise in supercritical fluid extraction, has developed a sustainable way to produce de-fatted lecithin powder that has less oil and longer shelf-life stability. The new process is semi-continuous and sustainable because it utilizes upcycled CO2 from waste sources instead of using toxic acetone which is the industry standard. - April 26, 2024 - Thar Process, LLC
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Groundbreaking Research Validates Biome Makers’ BeCrop Soil Intelligence Technology
Biome Makers, a global agtech company, proudly announces its contribution to the publication of two scientific studies validating the efficacy and reliability of the company’s revolutionary technology. These landmark papers demonstrate a significant leap forward in the field of soil health intelligence and predicting soil functionality. - April 06, 2024 - Biome Makers
Microvec Introduces New High Speed Particle Image Velocimetry Cameras
Microvec releases three new series of innovative high-speed cameras to use with Time Resolved Particle Image Velocimetry Systems. - March 29, 2024 - Microvec Pte Ltd
World's First LGBT Certified and ISO 17025 Accredited Calibration Laboratory
Joint Matters Inc., operating as Joint Matters Calibration Services, has been recognized as a certified LGBT Business Enterprise through NLGLCC. This company is also an accredited calibration laboratory for ISO 17025 under PJLA. The combination makes for the *world's first LGBT owned calibration lab (*as found from PJLA accredited lab search and NGLCC directory). - March 26, 2024 - Joint Matters, Inc.
AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry
California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper
Living Advantage, Inc. Collaborates with Post-Doctoral Student to Advance Nonprofit Research
A collaborative endeavor to enhance understanding of nonprofit operations and funding mechanisms through the lens of a French Researcher. - March 15, 2024 - Living Advantage Inc.
The University of Iowa Selects TrialX to Build SAYSTOP Study App for a Leading Research Study to Investigate Antibiotics Resistance
To study a patient-centered approach to antibiotic discontinuation upon symptom resolution in patients with acute uncomplicated pyelonephritis. - March 13, 2024 - TrialX